News

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
Vinay Prasad has worked as a professor of medicine ... He steps into the shoes vacated by Peter Marks, who resigned from the role a few weeks ago – reportedly before being pushed out ...
The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.
Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...
CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...
Prasad has questioned COVID-19 recommendations ... He takes over from Dr Peter Marks, who led the division for 13 years and played a major role in the COVID vaccine rollout. Marks resigned in ...
Axon named Tina Hahn as president and managing partner. Bristol Myers Squibb promoted Cari Gallman to EVP, general counsel ...
With a demand that vaccine boosters be tested against placebos, RFK Jr. puts an old antivaccine claim at the forefront of government health policy.
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.